HUL’s demerged ice cream arm Kwality Wall’s to debut on Feb 16

HUL had gone ex-ice cream business on December 5, with shareholders receiving one equity share of Kwality Wall’s India Ltd for every one share held in HUL.

HUL had gone ex-ice cream business on December 5, with shareholders receiving one equity share of Kwality Wall’s India Ltd for every one share held in HUL.

Ipca Laboratories reported a 31% rise in December quarter profit, supported by double-digit growth in Indian formulations and exports, while margins improved year-on-year. Shares traded higher following the announcement.

Under the agreement, Shilpa Medicare will develop and supply a novel asset targeting autoimmune and alloimmune disorders.

Eris Lifesciences posted a 19 percent net profit rise to ₹99.7 crore in Q3, with revenue up 10 percent to ₹807 crore and plans to acquire the remaining 30 percent in Swiss Parenterals for ₹423 crore.

Blue Jet Healthcare reported a sharp rise in December quarter profit, even as revenue and operating performance weakened year-on-year. Shares fell nearly 9% in intraday trade following the results announcement.

Gold and silver prices surged on MCX, driven by fresh trader positions and global gains. Experts highlight positive long-term outlooks amid demand and geopolitical factors.

Alkem Laboratories suffer the biggest single-day loss since February 2025. They have now breached both the 50-day and 100-day moving averages. The stock is about ₹80 away from 200-day moving average.

Siemens Energy India reported a 35% rise in Q1 profit with improved margins and strong backlog execution. The board approved ₹2,060 crore investment to expand transformer capacity under Make in India push.

The company’s EBITDA plunged 48.7% YoY to ₹46.6 crore in Q3FY26 compared to ₹91 crore in Q3FY25.

Punj Lloyd, once a major EPC firm, faced insolvency due to heavy debt and project failures. Adani Infra has now acquired it as a going concern after NCLT approval, offering hope for revival.